KeyBanc lowered the firm’s price target on Inspire Medical (INSP) to $234 from $236 and keeps an Overweight rating on the shares after the ...

Inspire Medical Systems, Inc. INSP announced preliminary revenues for the fourth quarter and full year 2024 yesterday. Despite the robust preliminary results, the company’s shares plunged nearly 13.4% ...

Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...

Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...

Inspire Medical Systems (NYSE:INSP – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at KeyCorp in a research note issued to investors on Friday,Benzinga ...

Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4 ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA ...

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems ...

Here is how AnaptysBio, Inc. (ANAB) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year.

Inspire Medical Systems, Inc. INSP announced preliminary revenues for the fourth quarter and full year 2024 yesterday. Despite the robust preliminary results, the company’s shares plunged nearly ...